Cardiac tissue engineering stands at the forefront of innovative medical research, representing a convergence of medicine, biology, and engineering. This cutting-edge field is driven by the urgent need to address the complexities of heart diseases and the limitations in organ transplantation. Researchers are pioneering novel strategies to overcome the scarcity of donor organs by leveraging biomaterials, stem cells, and advanced fabrication techniques. Through the meticulous construction of three-dimensional structures that closely emulate the heart's intricate architecture, scientists aim to create functional cardiac tissues in a laboratory setting. The overarching objective is to produce viable tissue replacements capable of seamlessly integrating into a patient's heart, fostering regeneration and restoring optimal cardiac function. This transformative approach holds immense promise in reshaping the landscape of cardiovascular disorder treatments, offering tailored solutions and diminishing reliance on conventional transplantation methods. Despite existing challenges, such as achieving electrical integration and vascularization, cardiac tissue engineering stands as a beacon of hope in advancing more effective therapies for heart-related conditions.
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : CARDIAC TROPONIN AND HOMOCYSTEINE LEVELS IN HEMODIALYSIS PATIENTS: ASSOCIATION WITH DIALYSIS VINTAGE AND CARDIOVASCULAR COMORBIDITY
Sofra Maria, Aretaieion University Hospital, Greece
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation